Connecting Psilocybin, Mushrooms, and Dreaming

Psilocybin, a psychedelic compound in magic mushrooms, triggers brain activity characteristic of dream states.

Written byJef Akst
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FLICKR, BHUMIKA B.Psilocybin, the psychedelic component of certain mushroom species that continues to be investigated for its use in treating anxiety and depression, elicits brain activity characteristic of someone who is dreaming, according to a study published July 3rd, 2014 in Human Brain Mapping.

“People often describe taking psilocybin as producing a dreamlike state and our findings have, for the first time, provided a physical representation for the experience in the brain,” Robin Carhart-Harris, a neuropsychopharmacology postdoc at Imperial College London, said in a press release.

Fifteen participants received injections of psilocybin and allowed their brain activity to be observed under an fMRI scanner. Under the influence of the compound, they exhibited increased brain activity in regions involved in emotion and memory, and the different areas of this network showed coordinated activity—the exact same pattern observed during dreaming. “You’re seeing these areas getting louder, and more active. It’s like someone’s turned up the volume there, in these regions that are considered part of an emotional system in the brain,” Carhart-Harris told The Washington Post. “When you look at a brain during dream sleep, you see the same hyperactive emotion centers.”

Moreover, participants who had received psilocybin had asynchronous activity in brain regions involved in high-level thinking, including our sense of self. Together, the results seem to validate the feelings of mind-broadening and selflessness that many report after taking magic mushrooms or other psychedelic drugs. Some have even described such trips as “waking dreams,” a description that now seems more appropriate than anyone realized.

Continue reading below...

Like this story? Sign up for FREE Newsletter updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

“A good way to understand how the brain works is to perturb the system in a marked and novel way. Psychedelic drugs do precisely this and so are powerful tools for exploring what happens in the brain when consciousness is profoundly altered,” lead author Enzo Tagliazucchi of Goethe University in Germany said in the release. “It is the first time we have used these methods to look at brain imaging data and it has given some fascinating insight into how psychedelic drugs expand the mind. It really provides a window through which to study the doors of perception.”

FAQ

What is psilocybin?

  • Psilocybin is a naturally-occurring compound produced by many mushroom species. Once in the body, the compound is metabolized to the active drug psilocin. Due to the effects of psilocin on the body, so-called magic mushrooms containing the compound are considered psychedelic drugs.

What do magic mushrooms do to the brain?

  • Psilocin made from psilocybin found in certain psychedelic mushrooms has mind-altering effects. Some of these include hallucinations, feeling of euphoria, and changes in perception and sense of time. Psychedelics act as neurotransmitters and affect multiple brain regions.

Do magic mushrooms affect sleep?

  • There is some evidence that psilocin alters sleep patterns in mice and humans in the short term.

What is the connection between psychedelic shrooms and dreaming?

  • Brain activity studies after psilocybin injection suggest that the compound increases brain function in areas associated with memory and emotion. These patterns were similar to what has been observed during dreaming, which implies that the drug creates a dreamlike state.

This article was originally published on July 3, 2014. It was updated on September 23rd by Niki Spahich, PhD.

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Image of a woman with her hands across her stomach. She has a look of discomfort on her face. There is a blown up image of her stomach next to her and it has colorful butterflies and gut bacteria all swarming within the gut.
November 2025, Issue 1

Why Do We Feel Butterflies in the Stomach?

These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".

View this Issue
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.

Long-Read RNA Sequencing Reveals a Regulatory Role for Splicing in Immunotherapy Responses

Pacific Biosciences logo
Research Roundtable: The Evolving World of Spatial Biology

Research Roundtable: The Evolving World of Spatial Biology

Conceptual cartoon image of gene editing technology

Exploring the State of the Art in Gene Editing Techniques

Bio-Rad
Conceptual image of a doctor holding a brain puzzle, representing Alzheimer's disease diagnosis.

Simplifying Early Alzheimer’s Disease Diagnosis with Blood Testing

fujirebio logo

Products

Labvantage Logo

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS

The Scientist Placeholder Image

Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics

OGT logo

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel